Dianthus Therapeutics, Inc. /DE/ (DNTH) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • Dianthus Therapeutics, Inc. /DE/ Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$103 M, a 76.1% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$103 M +$328 M +76.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$89.4 M -$43.6 M -95% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$78.9 M +$40 K +0.05% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$434 M -$68.7 M -18.8% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$431 M -$82.7 M -23.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$45.9 M -$28.5 M -164% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$78.9 M +$227 M +74.2% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$366 M -$76.9 M -26.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$349 M -$76.6 M -28.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$17.4 M +$237 M +93.2% Dec 31, 2021 8-K 2023-12-21
Q3 2021 -$306 M -$70 M -29.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$289 M -$70.3 M -32.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$272 M -$72.4 M -36.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$254 M -$74.9 M -41.7% Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$236 M -$80 M -51.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$219 M -$83.3 M -61.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$200 M -$81.9 M -69.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$179 M -$76.8 M -74.7% Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$156 M -$70.2 M -81.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 -$135 M -$65.2 M -93.2% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$118 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$103 M -$57.5 M -127% Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$86 M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$70 M Jun 30, 2018 10-Q 2018-08-09
Q4 2017 -$45.2 M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.